Dr. Mullins confirms that value in healthcare is incredibly important to both patients and insurance companies. The development of many new treatment options in the field of oncology makes it a prime place to look for value. Value can be determined by comparing evidence of cost and evidence of improved health outcomes.
When it comes to copays, cancer patients shoulder an unfair burden compared with other disease states. Dr. Bosserman talks about this need for a solution and the idea that a true, value-based system would help to make care more affordable for patients.
Are there specific initiatives at Atena that other health plans can adopt for value based cancer care
Results 1 - 5 of 5